Organon (OGN) EPS (Basic) (2020 - 2026)
Organon (OGN) posted quarterly EPS (Basic) of $0.41 for Q2 2026, down 26.28% year-over-year from $0.56 in Q2 2025, and down 26.66% on a QoQ basis from $0.56 in Q1 2026.
Organon (OGN) EPS (Basic) (2020 - 2026) Analysis & Trends
Organon has reported EPS (Basic) for 6 years, with the latest figure at $0.41 in Q2 2026.
- EPS (Basic) for Q2 2026 came in at $0.41, down 26.28% year-over-year; the trailing twelve-month figure through Jun 2026 was $0.8 (down 70.45% YoY), and the FY2025 annual result was $0.72, down 78.56% from the prior year.
- EPS (Basic) retreated to $0.41 in Q2 2026, from $0.56 in the prior quarter.
- Over five years, EPS (Basic) peaked at $2.14 in Q4 2023 and troughed at -$0.79 in Q4 2025.
- A 4-year average of $0.65 and a median of $0.59 in 2025 frame the typical range for EPS (Basic).
- The widest annual swing landed in 2024, when EPS (Basic) jumped 514.37%; it then sank 286.3% in 2025.
- A 4-year view of EPS (Basic) shows it stood at $2.14 in 2023, then plunged by 80.18% to $0.42 in 2024, then sank by 286.3% to -$0.79 in 2025, then jumped by 152.06% to $0.41 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were $0.41 in Q2 2026, $0.56 in Q1 2026, and -$0.79 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.31 Bn | 632.55 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 470.15 Bn | 463.58 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 377.27 Bn | 370.13 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 302.88 Bn | 295.19 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 257.92 Bn | 253.02 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 236.83 Bn | 222.84 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 160.37 Bn | 148.67 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn | 0.29 |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.41 |
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | -0.79 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.56 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | 1.39 |
| Jun 30, 2024 | 0.76 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 2.14 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.95 |
| Mar 31, 2023 | 0.70 |
| Jun 30, 2021 | -0.02 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | -0.05 |
| Jun 30, 2020 | -0.17 |
| Mar 31, 2020 | -0.12 |